KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Other Accumulated Expenses (2019 - 2022)

Biolife Solutions (BLFS) has disclosed Other Accumulated Expenses for 4 consecutive years, with $51000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Other Accumulated Expenses rose 131.82% to $51000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $51000.0, a 131.82% increase, with the full-year FY2022 number at $51000.0, up 131.82% from a year prior.
  • Other Accumulated Expenses was $51000.0 for Q4 2022 at Biolife Solutions, up from $22000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $986000.0 in Q4 2019 to a low of $22000.0 in Q4 2021.
  • A 4-year average of $200375.0 and a median of $130000.0 in 2020 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: tumbled 86.82% in 2020, then surged 131.82% in 2022.
  • Biolife Solutions' Other Accumulated Expenses stood at $986000.0 in 2019, then tumbled by 86.82% to $130000.0 in 2020, then tumbled by 83.08% to $22000.0 in 2021, then surged by 131.82% to $51000.0 in 2022.
  • Per Business Quant, the three most recent readings for BLFS's Other Accumulated Expenses are $51000.0 (Q4 2022), $22000.0 (Q3 2022), and $131000.0 (Q2 2022).